Taillefer de Laportalière T, Redon M, Roussin A, Willemet E, Very E, Olivier J, Lapeyre-Mestre M. First episode of catatonia followed by a psychotic episode related to chronic nitrous oxide use: A case report. Drug Alcohol Rev. 2025 Feb 3.
Alawoè C, Chapet N, Roubille F, Peyrière H, Eiden C. Narrative Review of Heart Failure Related to Cocaine Consumption and Its Therapeutic Management. J Clin Med. 2024 Nov 29;13(23):7275.
Duval M, Istvan M, Rousselet M, Laforgue EJ, Grall-Bronnec M, Mauriat C, Victorri-Vigneau C. ESCAPE Study: Cannabidiol Use in Patients Treated for Substance Use Disorders, Prevalence of Use, and Characteristics of Users. Eur Addict Res. 2024 Dec 2:1-12.
Lefebvre E, Simons L, Duval M, Laforgue EJ, Victorri-Vigneau C. Cannabinoid Hyperemesis Syndrome Presumed Secondary to CBD Use: A Case Report. J Addict Med. 2025 Jan-Feb 01;19(1):115-117
Cannabinoid Hyperemesis Syndrome Presumed Secondary to CBD Use: A Case Report. Lire la suite »
Duval M, Aquizerate A, Jaulin E, Rousselet M, Kuhn E, Guilleminot A, Nicolleau I, Pele S, Herault T, Artarit P, Soulidou-Jacques E, Laforgue EJ, Victorri-Vigneau C. Physicians, pharmacists and take-home naloxone: What practices? The SINFONI study. Therapie. 2024 Nov-Dec;79(6):623-633.
Physicians, pharmacists and take-home naloxone: What practices? The SINFONI study. Lire la suite »
Victorri-Vigneau C, Guerlais M, Jaulin E; FAN; Laforgue EJ, Pistorius MA. Thromboembolic complications following recreational use of nitrous oxide: A French Addictovigilance alert. Thromb Res. 2024 Sep;241:109096.
Bendjilali-Sabiani JJ, Eiden C, Lestienne M, Cherki S, Gautre D, Van den Broek T, Mathieu O, Peyrière H. Isotonitazene, a synthetic opioid from an emerging family: The nitazenes. Therapie. 2024 Nov-Dec;79(6):655-658.
Isotonitazene, a synthetic opioid from an emerging family: The nitazenes. Lire la suite »
Thomas C, Dondaine T, Caron C, Bastien A, Chérot N, Deheul S, Gautier S, Cottencin O, Moreau-Crépeaux S, Bordet R, Carton L. Factors associated with the use of benzodiazepine and opioid prescription drug in the student population: a cross-sectional study. Sci Rep. 2024 Jun 6;14(1):13040.
Lépine B, Debin M, Dassieu L, Gimenez L, Palmaro A, Ponté C, Swital M, Lapeyre-Mestre M, Blanchon T, Dupouy J. GPs’ practices when prescribing buprenorphine in primary care: A survey among the Sentinelles network. Therapie. 2024 Nov-Dec;79(6):646-654.
Maryse Lapeyre-Mestre, Florence Fabre, Emilie Jouanjus, The French Addictovigilance Network From the first pilot initiatives in the early 1990s to the national OSIAP survey in the 2020s: More than 30years of insight in medication diversion phenomenon in France,Therapies, 2024, ISSN 0040-5957, https://doi.org/10.1016/j.therap.2024.10.053. L’article est disponible en accès libre jusqu’au 28 décembre 2024 en cliquant sur ce lien :https://authors.elsevier.com/a/1k3s%7E9EljjM6Q